Filter by: Subject

Results Per Page:

Filter by: Subject

225Ac-PSMA-617 (1)
68Ga-citrate (1)
68Ga-PSMA (2)
Behandlung (1)
Bins (1)
Bioassay (1)
Biomaterials (1)
Black South-African (BSAs) (1)
Blood–brain barrier (BBB) (1)
Bone SPECT-CT (1)
Breast cancer (2)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)
Chromatography (1)
Colorectal cancer (1)
Computed tomography (CT) (2)
Computerized tomography (CT) (1)
Computerized tomography' (CT) (1)
Cryptic peptides (1)
Dichroism (1)
Drug products (1)
FDG PET/CT (1)
FDG-PET (1)
FDG-PET imaging (1)
Fludeoxyglucose (FDG) (1)
Fluorine-18-Fluorodeoxyglucose (FDG) (1)
Functional characterization (1)
GHR bioassay (1)
Growth hormone receptor (GHR) (1)
Highly active antiretroviral therapy (HAART) (1)
HIV infection (1)
Human growth hormone (1)
Immunohistochemistry (IHC) (1)
Inherent complexity (1)
Isomers (1)
Lipodystrophy (1)
Loosening (1)
Lumbar fusion (1)
Lung lesions (1)
Mass spectrometry (1)
Metastatic prostate carcinoma (1)
Multiple substitutions (1)
Native mass spectrometries (1)
Native MS (1)
Non-prostate carcinoma (1)
Ovarian cancer (1)
Overall survival (OS) (1)
Patient management (1)
Patienten management (1)
Pedicle screws (1)
PET/CT (3)
Physico-chemical characterization (1)
Positron emission tomography (PET) (6)
Primary prostate carcinoma (PPC) (1)
Progression-free survival (PFS) (1)
Prostate carcinoma (3)
Prostate-specific membrane antigen (PSMA) (4)
Proteins (1)
PSA response (1)
Pulmonary (1)
Quality control (1)
Racial differences (1)
Radioligand therapy (1)
Recombinant human growth hormones (1)
Serum tumor markers (1)
Signal transduction (1)
Single photon emission computed tomography (SPECT) (1)
Size exclusion chromatography (1)
Somatropin (1)
Substitution degree (1)
Synthetic somatropin-derived peptide (SDP) (1)
TB (1)
Tissue distribution (1)
Treatment (1)
Tuberculosis (1)
Tuberculosis (TB) (2)
Tuberculosis -- Treatment (1)
Tuberkulose (TB) (1)